[Histonet] Invitation from Dr. Helen Moore, OBBR, NCI to attendFree BRN Sypmposium in March

[Dr. Andrea Kelly]

The National Cancer Institute (NCI) Office of Biorepositories and 
Biospecimen Research (OBBR) and the National Institutes of Health Office 
of Rare Diseases announce the Biospecimen Research Network (BRN) Symposium:

 

*"/Advancing Cancer Research Through Biospecimen Science"/*

*March 13-14, 2008*

Renaissance M Street Hotel

1143 New Hampshire Avenue NW

Washington, D.C.

 

The primary goal of the symposium is to address the significant impact 
of pre-analytical biospecimen variability on cancer research and 
molecular medicine.

 

The symposium will feature expert presentations and interactive 
discussions on topics in biospecimen science including:

·         /HER2/neu/: Lessons Learned

·         Access to Existing Knowledge in Biospecimen Science

·         Research Advances in Biospecimen Science

·         Assessing and Qualifying Biospecimen Quality

·         Patient's Perspective on Biospecimen Quality

·         Incorporating Biospecimen Science Into Research and Clinical 
Practice

 

Key presenters to address the significant impact of biospecimen 
variability in cancer research and recent advances in biospecimen 
science include:

·                     Patrick O. Brown, M.D., Ph.D., Stanford University 
School of Medicine

·                     Carolyn C. Compton, M.D., Ph.D., OBBR, NCI

·                     Angelo deMarzo, M.D., Ph.D., Johns Hopkins University

·                     Theo deVos, Ph.D., Epigenomics, Inc. 

·                     Steve Gutman, M.D., M.B.A., Food and Drug 
Administration

·                     Elizabeth Hammond, M.D., FCAP, University of 
Utah/LDS Hospital Daniel Hayes, M.D., University of Michigan

·                     Scott Jewell, Ph.D., Ohio State University

·                     Paula Kim, Translating Research Across Communities

·                     Lance Liotta, M.D, Ph.D., George Mason University

·                     Chris Logothetis, M.D., M.D. Anderson Cancer Center

·                     Scott D. Patterson, Ph.D., Amgen Inc.

·                     David Ransohoff, M.D., University of North 
Carolina at Chapel Hill

·                     Gerry Thomas, Ph.D. Imperial College London, 
United Kingdom

·                     Paul Waring, Ph.D., Genentech, Inc.

·                     and others

 

This interactive symposium is free and open to the public and is 
expected to be of particular value to research investigators, 
clinicians, government representatives, industry representatives, and 
patient advocates. *For more information, to register, and to submit an 
abstract, please visit www.brnsymposium.com <http://www.brnsymposium.com/>.*

* *

We apologize if you receive more than one copy of this notice. Please 
share this notice with any interested colleagues. We look forward to 
your participation. If you have any questions about the meeting or 
registration, please contact Marlene Goldman at 
mgoldman <@t> md.capconcorp.com or 301-468-6004 ext. 416.

 

 

Sincerely,

 

Helen M. Moore, Ph.D.

Biospecimen Research Network Program Manager

Office of Biorepositories and Biospecimen Research

Office of the Director

National Cancer Institute

31 Center Drive, 31/10A03

Bethesda, MD 20892-2590

Phone:  (301) 496-1550

Fax:  (301) 480-4814

E-mail:  moorehe <@t> mail.nih.gov <mailto:moorehe <@t> mail.nih.gov>

http://biospecimens.cancer.gov <http://biospecimens.cancer.gov/>

-- 

Posted by
Andrea Kelly, Ph.D.

Rose Li & Associates
Contractor to NCI, OBBR